IMGN up on extended deal

ImmunoGen (IMGN) gained $0.42 to $6.35 on Wednesday after sanofi-aventis (Euronext:SAN; SNY) extended for one year a 2003 deal to co-develop cancer antibodies using targets from both companies. SAN wi...